APOC3 and metabolic dysfunction-associated steatotic liver disease: A number of previous studies have examined the genetic impact of apolipoprotein C3 (APOC3) polymorphisms on NAFLD (Jain et al., 2019[24]; Xu et al. 2020[56]).